Clinical Trial Update: A Study Of Efficacy And Safety Of Fesoterodine In Vulnerable Elderly Subjects With Overactive Bladder [Phase 4]

View source ↗

Summary

A Phase 4 study evaluated the efficacy and safety of fesoterodine in vulnerable elderly subjects with overactive bladder; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Fesoterodine (fesoterodine)

Snippet

Sponsor: Pfizer | Conditions: Overactive Bladder | Phase 4 | Status: COMPLETED | Results posted: 2013-01-17